Skip to content

Multicenter Infection Surveillance Study Following Colorectal Procedures

Phase IV Multicenter Infection Surveillance Study Following Colorectal Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00762060
Acronym
MISS
Enrollment
289
Registered
2008-09-30
Start date
2006-11-30
Completion date
2007-09-30
Last updated
2015-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection

Keywords

colorectal surgery

Brief summary

This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal surgical procedures.

Detailed description

This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal procedures.

Interventions

DEVICEON-Q Silver soaker System

Continuous infusion of local anesthetic to surgical site

DRUGPatient controlled analgesia

IV opioids delivered via PCA

Sponsors

Halyard Health
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women, \>18 years of age; * Scheduled for elective colon procedure; * Ability to complete patient survey questionnaires; * Provision of informed consent

Exclusion criteria

* Patients with a prior allergic reaction to Morphine, Demerol, Dilaudid, Fentanyl, Marcaine (bupivacaine), lidocaine or Naropin (ropivacaine); * Procedures for hemorrhoids; * Inability to perform follow up assessments

Design outcomes

Primary

MeasureTime frame
Surgical site infection30 days postoperative

Secondary

MeasureTime frame
Hospital length of stayAverage 1 week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026